ClinicalTrials.gg
Sign In

Carcinoma, Endometrioid clinical trials

The registry lists 46 studies for Carcinoma, Endometrioid across more than 10 countries. 11 are recruiting or about to start. 31 of them are mainly about Carcinoma, Endometrioid (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Carcinoma, Endometrioid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
16
Recruiting
11
Active, not recruiting
8
Withdrawn
6
Terminated
3
Status unknown
2

Phase

Phase 2
23
Phase 1
9
Phase 3
3
Early Phase 1
2

Where

United States
32
Canada
9
China
4
United Kingdom
3
Spain
3
France
2

Who runs them

National Cancer Institute (NCI) (14) · Mayo Clinic (4) · Peking University People's Hospital (3) · Gynecologic Oncology Group (2) · Memorial Sloan Kettering Cancer Center (2) · Institute of Cancer Research, United Kingdom (2) · M.D. Anderson Cancer Center (2) · MedSIR (1)

What is being tested here

Drugs under test in Carcinoma, Endometrioid studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ipilimumab102
Carboplatin102
Paclitaxel102
Pembrolizumab101
Sapanisertib101
Serabelisib101
Nivolumab002
Capivasertib001
Cediranib001
Durvalumab001

Drug classes tested here Immune checkpoint inhibitors 2 open · Tyrosine kinase inhibitors (TKIs) 4

Coming up

1phase 3 study under way
5studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5, phase 3 first

Who these studies take

Of the 11 Carcinoma, Endometrioid studies recruiting now, 8 (73%) set no upper age limit and 3 (27%) stop at 75 or younger. 3 (27%) take children under 18. 9 (82%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
103 (27%)2 (18%)
1811 (100%)2 (18%)
3011 (100%)2 (18%)
4011 (100%)2 (18%)
508 (73%)2 (18%)
658 (73%)2 (18%)
758 (73%)2 (18%)
858 (73%)2 (18%)

Across all 46 studies, recruiting or not: 7% stop at 75 or younger and 7% at 65; 13% take children; 78% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 46 of 46. search them.